This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Wednesday's Small-Cap Winners & Losers

Ceco Environmental (CECE - Get Report) jumped on news of two orders for its air pollution control systems, totaling more than $55 million, for automotive facilities in the Southeast and in the Midwest. The Cincinnati-based company was up 92 cents, or 10.3%, to $9.89.

Biomira (BIOM) rose after the Canadian biotech announced it had opened two drug trials to patient enrollment. One of these -- an advanced-phase trial for Stimuvax, a proposed treatment for lung cancer -- will trigger a milestone payment from Merck upon enrollment of its first patient. This is expected to occur sometime in January. Shares were gaining 11 cents, or 9.7%, to $1.25.

Trans World Entertainment (TWMC - Get Report) shares slid as the Albany, N.Y.-based retailer sharply cut its full-year outlook after a disappointing holiday shopping season. The company, which operates such chain stores as Sam Goody, f.y.e. and Coconuts, now forecasts earnings between break-even and a nickel a share, down from its previous range between 10 cents and 20 cents. Analysts polled by Thomson Financial are looking for 6 cents a share. Shares were down 50 cents, or 7.6%, to $6.08.

NetBank (NTBK) fell after the Georgia-based online bank privately sold 6.5 million of its shares for $3.90 each, a discount to its $4.64 closing price Friday. Total proceeds are expected at about $23.7 million. The transaction will likely close at the end of the week. Shares were off 33 cents, or 7.1%, to $4.31.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs